You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!
Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA. ENOB is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
Los Angeles, California
52 Week High
52 Week Low